(Reuters) - Amicus Therapeutics Inc said its experimental drug significantly reduced the abnormal accumulation of fat in body cells related to a rare genetic disorder that could lead to heart attack, stroke and kidney failure. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/2kZhEHiNYck/story01.htm
Read More
No comments:
Post a Comment